Nasal Microflora in Patients with Flu and Acute Upper Respiratory Viral Infections, Which was Isolated in Ternopil Clinics in 2017

During annual influenza epidemics the incidence is about 10% of the population, and during pandemics that number increases by 4-6 times. In fact all influenza epidemies accompanied increase mortality. Worldwide annual deaths from influenza and acute upper respiratory tract infections (URTI) is over 4,5 million people (for comparison, the death rate from tuberculosis – 3,1 million people, malaria – 2,2 million people hepatitis – 1,1 million. people). In Ukraine in 2014 about 6 million citizens with symptoms of influenza and URTI appealed for medical help [1]. Pulmonary complications of influenza are most common include secondary bacterial infection [2].The human upper respiratory tract is the reservoir of a diverse community of commensals and potential pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus, which occasionally turn into pathogens causing infectious diseases [3-5]. Bacterial complications such as otitis media and acute sinusitis and others are possible [6].